Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Recombinant Human Thrombopoietin Injection

Approval Number

国药准字S20050049

Company沈阳三生制药有限责任公司

Registration Date

July 13, 2020

Drug Information

Generic Name

重组人血小板生成素注射液

Trade Name

特比澳

Brand Name

特比澳

Dosage Form

注射剂

Strength

7500U/1ml

Drug Type

生物制品

Registration Date

July 13, 2020

Company Information

Applicant Company

Company Name沈阳三生制药有限责任公司

Company Address

沈阳经济技术开发区十号路1甲3号

Manufacturing Company

Company Name沈阳三生制药有限责任公司

Company Address

沈阳经济技术开发区十号路1甲3号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy